Insight into drug sensitizing effect of diallyl disulfide and diallyl trisulfide from Allium sativum L. on paclitaxel-resistant triple-negative breast cancer cells R Marni, DB Kundrapu, A Chakraborti, RR Malla Journal of Ethnopharmacology 296, 115452, 2022 | 27 | 2022 |
Tumor-associated macrophages: Potential target of natural compounds for management of breast cancer RR Malla, V Padmaraju, DB Kundrapu Life Sciences 301, 120572, 2022 | 16 | 2022 |
Quercetin and taxifolin inhibits TMPRSS2 activity and its interaction with EGFR in paclitaxel‐resistant breast cancer cells: An in silico and in vitro study DB Kundrapu, AK Chaitanya, K Manaswi, S Kumari, RR Malla Chemical Biology & Drug Design 104 (2), e14600, 2024 | 2 | 2024 |
Unleashing the Power of Yes-Associated Protein in Ferroptosis and Drug Resistance in Breast Cancer, with a Special Focus on Therapeutic Strategies RR Malla, DB Kundrapu, P Bhamidipati, GP Nagaraju, N Muniraj Cancers 15 (24), 5728, 2023 | 2 | 2023 |
Advances in Quercetin for Drug-Resistant Cancer Therapy: Mechanisms, Applications, and Delivery Systems DB Kundrapu, RR Malla Critical Reviews™ in Oncogenesis 28 (4), 2023 | 1 | 2023 |
Enhanced efficacy of quercetin and taxifolin encapsulated with pH-responsive injectable BSA hydrogel for targeting triple-negative breast cancer cells DB Kundrapu, PA Rao, RR Malla International Journal of Biological Macromolecules 287, 138477, 2025 | | 2025 |
Natural Compounds: Recent Updates in Targeting Colon Cancer Growth and Its Metastasis RR Malla, DB Kundrapu Onco Therapeutics 9 (1), 2022 | | 2022 |
Advances in Quercetin for Drug-Resistant Cancer Therapy: Mechanisms, Applications, and Delivery Systems RR Malla, DB Kundrapu Critical Reviews™ in Oncogenesis, 0 | | |